| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |